Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 14, 2020 08:00 ET | Source: ImmuCell Corporation

ImmuCell Receives $938,000 in Support under the Paycheck Protection Program

PORTLAND, Maine, April 14, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
April 02, 2020 16:29 ET | Source: ImmuCell Corporation

ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020

PORTLAND, Maine, April 02, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
March 11, 2020 16:05 ET | Source: ImmuCell Corporation

ImmuCell Announces Refinancing of its Bank Debt

PORTLAND, Maine, March 11, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
February 19, 2020 12:35 ET | Source: ImmuCell Corporation

ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019

PORTLAND, Maine, Feb. 19, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
February 18, 2020 16:05 ET | Source: ImmuCell Corporation

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019

PORTLAND, Maine, Feb. 18, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
February 13, 2020 09:17 ET | Source: ImmuCell Corporation

ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019

PORTLAND, Maine, Feb. 13, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
January 21, 2020 12:30 ET | Source: ImmuCell Corporation

ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019

PORTLAND, Maine, Jan. 21, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
November 11, 2019 16:05 ET | Source: ImmuCell Corporation

ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019

PORTLAND, Maine, Nov. 11, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
November 05, 2019 08:00 ET | Source: ImmuCell Corporation

ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019

PORTLAND, Maine, Nov. 05, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company that develops, manufactures and markets...
September 17, 2019 08:00 ET | Source: ImmuCell Corporation

ImmuCell Enters into Lease Agreement for a Facility to Expand First Defense® Production Capacity

PORTLAND, Maine, Sept. 17, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, manufactures and markets...